Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Machine Learning for Designing Next-Generation mRNA Therapeutics
Sebastian M. Castillo-Hair, Georg Seelig
Accounts of Chemical Research (2021) Vol. 55, Iss. 1, pp. 24-34
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 114
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 52
How will generative AI disrupt data science in drug discovery?
Jean‐Philippe Vert
Nature Biotechnology (2023) Vol. 41, Iss. 6, pp. 750-751
Closed Access | Times Cited: 49
Tailor made: the art of therapeutic mRNA design
Mihir Metkar, Christopher S. Pepin, Melissa J. Moore
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 67-83
Closed Access | Times Cited: 47
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives
Nian‐Nian Zhong, Hanqi Wang, Xinyue Huang, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 52-74
Closed Access | Times Cited: 45
Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Designing nanotheranostics with machine learning
Lang Rao, Yuan Yuan, Xi Shen, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 31
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 25
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 10
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Mayur Suresh Gawande, N. N. Zade, Praveen Kumar, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 6
mRNA-Based Therapeutics in Cancer Treatment
Han Sun, Yu Zhang, Ge Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 622-622
Open Access | Times Cited: 31
Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning
Sebastian M. Castillo-Hair, Stephen Fedak, Ban Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Codon-optimization in gene therapy: promises, prospects and challenges
Anastasiia Iu. Paremskaia, Anna A. Kogan, А. А. Мурашкина, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 15
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 12
The regulatory landscape of 5′ UTRs in translational control during zebrafish embryogenesis
Madalena M. Reimão-Pinto, Sebastian M. Castillo-Hair, Georg Seelig, et al.
Developmental Cell (2025)
Open Access | Times Cited: 1
Enhancing mRNA translation efficiency by introducing sequence optimized AU rich elements in 3’UTR via HuR anchorage
Xinghuan Ma, S W Liu, Bangda Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102485-102485
Open Access | Times Cited: 1
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Bright Future of mRNA as a Therapeutic Molecule
Dora Emma Vélez, Blanca Licia Torres, Greco Hernández
Genes (2025) Vol. 16, Iss. 4, pp. 376-376
Open Access | Times Cited: 1
Artificial Intelligence in battling infectious diseases: A transformative role
Chunhui Li, Guoguo Ye, Yinghan Jiang, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 8
mRNA Vaccine Sequence and Structure Design and Optimization: Advances and Challenges
Lei Jin, Yuanzhe Zhou, Sicheng Zhang, et al.
Journal of Biological Chemistry (2024), pp. 108015-108015
Open Access | Times Cited: 7
An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma
Zhuoya Deng, Hao Yang, Yuying Tian, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers
Xumei Ouyang, Yu Liu, Ke Zheng, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 19, Iss. 1, pp. 100883-100883
Open Access | Times Cited: 16
Messenger RNA Therapy for Female Reproductive Health
Rachel VanKeulen-Miller, Owen S. Fenton
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 393-409
Closed Access | Times Cited: 6
The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution
Fırat Özçelik, Mehmet Sait Dündar, Abdulbaki Yildirim, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 4
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top